Search Results 7111-7120 of 37535 for oral

  1. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...

  2. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...

  3. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...

  4. Medical Research & Education - Mayo Clinic News Network

    New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show · Mayo Clinic researchers use AI to predict patient falls ...

  5. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...

  6. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...

  7. Patricio C. Gargollo, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerAmerican Board of Urology. 2021 - present. MemberMERG Latino Committee. 2020 - present. Urology Care Foundation Spanish Translation Work Group ...

  8. Fermented Diet on Microbiome Diversity in Long COVID - Mayo Clinic

    Unable to tolerate oral foods; Potential contraindications to a fermented food diet (including chronically immunosuppressed including organ transplant ...

  9. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    Known allergy or intolerance to oral vancomycin. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most ...

  10. MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer - Mayo Clinic

    Treatment with oral/systemic corticosteroids, with the exception of topical or inhaled steroids. Exposure to household contacts ≤ 15 months old or ...